Streetbeat News

Products Services

PANW

Financial giants have shown significant interest in Palo Alto Networks (NASDAQ:PANW) through unusual options activity. Analysis reveals a mix of bullish and bearish trades, with a notable range of price targets from $200 to $650. The stock is currently trading at $326.13, down by 1.61%, with a neutral RSI. Analysts have mixed ratings, with price targets ranging from $325 to $380.

Portfolio Pulse from Benzinga Insights

August 12, 2024 | 2:01 pm

DAL

TMUS

Delta Air Lines has started rolling out free Wi-Fi presented by T-Mobile on select long-haul international routes.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 2:00 pm

BTCUSD

COREUSD

Copper has announced a partnership with Core Foundation to enable institutional clients to stake Bitcoin and CORE tokens directly from their Copper accounts. This partnership expands Copper's services to include non-custodial BTC staking, enhancing capital efficiency for institutional investors.

Portfolio Pulse from Murtuza Merchant

August 12, 2024 | 1:51 pm

ETHUSD

Ethereum has been underperforming, down 15% over the past 30 days. However, on-chain data and technical analysis suggest a potential bullish rebound. Significant liquidations in the futures market may lead to renewed interest and a price surge. Traders are divided, with some seeing potential while others note competition from Bitcoin and Solana. Institutional interest in Ethereum will be discussed at Benzinga’s Future of Digital Assets event on Nov. 19.

Portfolio Pulse from Khyathi Dalal

August 12, 2024 | 1:41 pm

BKR

HAL

USO

VTS

XLE

XOP

Oil prices are set for a fourth consecutive day of gains, driven by geopolitical risks despite OPEC's reduced demand forecast. Key US-listed assets like USO, XLE, HAL, BKR, XOP, and VTS are seeing positive premarket movements.

Portfolio Pulse from Piero Cingari

August 12, 2024 | 1:28 pm

TLS

Telos Corporation is expanding its TSA PreCheck enrollment services to seven new locations across Illinois, Indiana, Louisiana, Michigan, Minnesota, Texas, and Washington starting August 12, 2023.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 1:26 pm

HUMA

The FDA has announced a delay in the review of Humacyte Inc.'s Biologic License Application for its acellular tissue-engineered vessel (ATEV) for vascular trauma injuries. The original PDUFA date was August 10, 2024, but the new action date is currently undisclosed. This delay has caused Humacyte's stock to drop by 8.98% in premarket trading.

Portfolio Pulse from Vandana Singh

August 12, 2024 | 1:21 pm

WVE

Wave Life Sciences shares are trading higher after the company announced that the FDA has granted Rare Pediatric Disease Designation to WVE-N531 for the treatment of Duchenne muscular dystrophy.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 1:19 pm

SXTP

60 Degrees Pharma has granted the University of Kentucky the right of reference to its New Drug Application (NDA) for ARAKODA. This will facilitate a Phase IIb clinical study of SJ733 for Vivax malaria, combining SJ733 with a single dose of Tafenoquine.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 1:14 pm

SDST

Stardust Power Inc. (NASDAQ:SDST) has selected Primero USA to complete a definitive engineering study for its lithium refinery in Muskogee, Oklahoma. This study is crucial for the development of battery-grade lithium products.

Portfolio Pulse from Benzinga Newsdesk

August 12, 2024 | 1:14 pm